Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Amarin Corp. Names CEO | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Amarin Corp. Names CEO

Thero succeeds Zakrzewksi

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

John F. Thero, current president of Amarin Corp., has been appointed president and chief executive officer of the company, and will serve on the board of directors, effective January 1, 2014. He succeeds Joseph S. Zakrzewksi, who plans to retire as chief executive officer and chairman of the board. Lars Ekman, M.D., Ph.D., who currently serves as lead independent director, will become chairman of the board. Mr. Zakrzewski will remain on the board.
 
“It is with great pleasure and confidence that we appoint John Thero as president and chief executive officer of Amarin. John has been a key executive of Amarin since November 2009 and has contributed substantial executive leadership and operational value to the company. Expanding John’s role was the natural decision as the company embarks on the next stages of its commercial growth,” said Dr. Ekman. “On behalf of Amarin’s employees and Board of Directors, I thank Joe Zakrzewski for the commitment, dedication and leadership he has provided since joining Amarin. We are pleased to have Joe continue as a member of the Board of Directors as we move forward.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters